Bright Minds Biosciences ...

NASDAQ: DRUG · Real-Time Price · USD
41.80
-0.74 (-1.74%)
At close: Aug 15, 2025, 3:59 PM
41.12
-1.64%
Pre-market: Aug 18, 2025, 04:00 AM EDT

Bright Minds Biosciences Income Statement

Financials in CAD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-2.62M -7.2M -14.73M -8.62M
Interest Income
n/a n/a n/a n/a
Pretax Income
-2.8M -7.37M -14.96M -8.65M
Net Income
-2.8M -7.37M -14.96M -8.65M
Selling & General & Admin
1.44M 2.2M 2.55M 2.31M
Research & Development
1.18M 5M 12.18M 6.31M
Other Expenses
n/a n/a -0.00 0.00
Operating Expenses
2.62M 7.2M 14.73M 8.62M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
41.6K 119.42K 551.86K 852.15K
Cost & Expenses
2.62M 7.2M 14.73M 8.62M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
4.31M 3.72M 2.47M 1.79M
Shares Outstanding (Diluted)
4.31M 3.72M 2.47M 1.79M
EPS (Basic)
-0.65 -1.98 -6.15 -4.74
EPS (Diluted)
-0.65 -1.98 -6.15 -4.74
EBITDA
n/a -7.28M -14.96M n/a
EBIT
-2.62M -7.35M -14.73M -8.65M
Depreciation & Amortization
2.62M 72.45K 6.04K 8.62M